Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for blocking inflammation factors of patient suffering from articular cartilage injuries in knee arthritis

A technology for articular cartilage and knee arthritis, applied in the field of medicine and biology, can solve the problems of family and social burden and high operation cost

Inactive Publication Date: 2017-06-13
SHANDONG JINGYUAN BIOTECH CO LTD
View PDF6 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For the elderly and patients with severe late symptoms and poor conservative treatment effect, artificial knee replacement is required. Not only the operation cost is high, it will cause serious burden to the patient, family and society, and a second operation is required

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for blocking inflammation factors of patient suffering from articular cartilage injuries in knee arthritis
  • Medicine for blocking inflammation factors of patient suffering from articular cartilage injuries in knee arthritis
  • Medicine for blocking inflammation factors of patient suffering from articular cartilage injuries in knee arthritis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0081] 1X10 7 cells / ml umbilical cord mesenchymal stem cells and 10 ng / ml superoxide dismutase and 5 ng / ml vitamin D.

Embodiment 2

[0083] 1X10 7 cells / ml umbilical cord mesenchymal stem cells and 15ng / ml superoxide dismutase and 8ng / ml vitamin D.

Embodiment 3

[0085] 1X10 7 cells / ml umbilical cord mesenchymal stem cells and 25ng / ml superoxide dismutase and 15ng / ml vitamin D.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medical biology and relates to a medicine for blocking inflammation factors of a patient suffering from articular cartilage injuries in knee arthritis. The medicine is characterized by being prepared from components as follows: 1*10<7> cell / ml umbilical cord mesenchymal stem cells, 10-25 ng / ml superoxide dismutase and 5-15 ng / ml vitamin D. The medicine is a novel medicine combination for treating Parkinson's disease clinically and can remarkably reduce the rising LDH level of lymphocyte of a Parkinson patient. The umbilical cord mesenchymal stem cells, superoxide dismutase and vitamin D compound drugs can be used for treating articular cartilage injuries in knee arthritis and have a good effect.

Description

technical field [0001] The invention belongs to the technical field of medicine and biology, and relates to a novel medicine for blocking inflammatory factors in patients with articular cartilage damage caused by knee arthritis by using umbilical cord mesenchymal stem cells, superoxide dismutase and vitamin D compound medicine. Background technique [0002] Articular cartilage damage in knee arthritis is more likely to occur in middle-aged and elderly people and people engaged in heavy-duty sports. The clinical manifestations are mainly two aspects: joint pain and motor dysfunction. At present, the clinical treatment effect is not good, mainly to relieve the pain of patients and improve the function of the knee joint. The reason is that the pathogenesis of cartilage damage in knee arthritis is not clear. Drug therapy is mainly symptomatic treatment, which temporarily relieves the pain of the patient, but the long-term effect is not good, and the symptoms are prone to repeate...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/44A61P19/02A61P29/00A61K35/28A61K31/59
CPCA61K38/446A61K9/0014A61K31/59A61K35/28C12Y115/01001A61K2300/00
Inventor 崔超罗光会杨继建田丽娜
Owner SHANDONG JINGYUAN BIOTECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products